ANTI-CD123 CHIMERIC ANTIGEN RECEPTOR REDIRECTED T CELLS FOR RELAPSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

被引：0
|
作者：
Ruella, M. [1 ]
Shestova, O. [1 ]
Kenderian, S. [1 ]
Barrett, D. [2 ]
Grupp, S. [2 ]
Scholler, J. [1 ]
Lacey, S. [1 ]
Kalos, M. [1 ]
June, C. H. [1 ]
Gill, S. [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA
来源：
CYTOTHERAPY | 2014年 / 16卷 / 04期
关键词：
D O I：
10.1016/j.jcyt.2014.01.017
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
5
引用
下载
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [41] Balance of anti-CD123 Chimeric Antigen Receptor (CAR) binding affinity and density in an in vitro model of Acute Myeloid Leukemia
    Arcangeli, S.
    Bardelli, M.
    Rotiroti, M. C.
    Simonelli, L.
    Magnani, C. F.
    Biondi, A.
    Tettamanti, S.
    Varani, L.
    Biagi, E.
    HUMAN GENE THERAPY, 2016, 27 (11) : A43 - A43
  • [42] Cost-effectiveness of Anti-CD19 chimeric antigen receptor T-Cell therapy in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia. A societal view
    Thielen, Frederick W.
    van Dongen-Leunis, Annemieke
    Arons, Alexander M. M.
    Ladestein, Judith R.
    Hoogerbrugge, Peter M.
    Uyl-de Groot, Carin A.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 105 (02) : 203 - 215
  • [43] Anti-CD123 Chimeric Antigen Receptor T Cells (CART-123) Provide A Novel Myeloablative Conditioning Regimen That Eradicates Human Acute Myeloid Leukemia In Preclinical Models
    Gill, Saar
    Tasian, Sarah K.
    Ruella, Marco
    Shestova, Olga
    Li, Yong
    Porter, David L.
    Carroll, Martin
    Danet-Desnoyers, Gwenn
    Scholler, John
    Grupp, Stephan A.
    June, Carl H.
    Kalos, Michael
    BLOOD, 2013, 122 (21)
  • [44] Safety and efficacy of a humanized CD19 chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic leukemia
    Shi, Ming
    Li, Li
    Wang, Shiyuan
    Cheng, Hai
    Chen, Wei
    Sang, Wei
    Qi, Kunming
    Li, Zhenyu
    Wang, Gang
    Li, Huizhong
    Lan, Jianping
    Huang, Jinqi
    Fei, Xiaoming
    Yu, Min
    Li, Fei
    Qiao, Jianlin
    Wu, Qingyun
    Zeng, Lingyu
    Jing, Guangjun
    Zheng, Junnian
    Gale, Robert Peter
    Xu, Kailin
    Cao, Jiang
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (06) : 711 - 718
  • [45] Chimeric Antigen Receptor T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia Current Landscape in 2021
    Gauthier, Jordan
    Turtle, Cameron J.
    CANCER JOURNAL, 2021, 27 (02): : 98 - 106
  • [46] Infections in children following chimeric antigen receptor T-cell therapy for B-cell acute lymphoblastic leukemia
    Diamond, Yonatan
    Gilsenan, Maddie
    Wang, Stacie Shiqi
    Hanna, Diane
    Conyers, Rachel
    Cole, Theresa
    Hughes, David
    Fleming, Jacqueline
    Meyran, Deborah
    Toro, Claudia
    Malalasekera, Vajiranee
    Khaw, Seong Lin
    Haeusler, Gabrielle M.
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25 (06)
  • [47] CD19-targeted chimeric antigen receptor (CAR) T cells in CNS relapsed acute lymphoblastic leukemia (ALL).
    Newman, Haley
    Leahy, Allison Emily Barz
    Li, Yimei
    Liu, Hongyan
    Myers, Regina M.
    DiNofia, Amanda M.
    Dolan, Joseph Gregory
    Callahan, Colleen
    Devine, Kaitlin J.
    Wray, Lisa
    June, Carl H.
    Grupp, Stephan A.
    Rheingold, Susan R.
    Maude, Shannon L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [48] Anti-CCR9 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemia
    Maciocia, Paul M.
    Wawrzyniecka, Patrycja A.
    Maciocia, Nicola C.
    Burley, Amy
    Karpanasamy, Thaneswari
    Devereaux, Sam
    Hoekx, Malika
    O'Connor, David
    Leon, Theresa
    Rapoz-D'Silva, Tanya
    Pocock, Rachael
    Rahman, Sunniyat
    Gritti, Giuseppe
    Yanez, Diana C.
    Ross, Susan
    Crompton, Tessa
    Williams, Owen
    Lee, Lydia
    Pule, Martin A.
    Mansour, Marc R.
    BLOOD, 2022, 140 (01) : 25 - 37
  • [49] Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia
    Badar, Talha
    Shah, Nirav N.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (02)
  • [50] Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia
    Talha Badar
    Nirav N. Shah
    Current Treatment Options in Oncology, 2020, 21
12345